qrx008

Generic: VLA-4 inhibitor

qrx008: developed by 1 company. Updated within the last hour.

Development Pipeline (1)

CompanyPhase
Quoin Pharmaceuticals, Ltd. (QNRX)Phase 2/Phase 3

Get deeper analysis on qrx008

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    qrx008 — Drug Pipeline, Trials & FDA Status | BioSniper